Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
HELSINN HEALTHCARE S.A. et al v. DR. REDDY'S LABORATORIES, LTD. et al
Case Number:
3:14-cv-04274
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 13, 2015
CORRECTED: Helsinn, Dr. Reddy's Settle Patent Suit Over Generic Aloxi
Dr. Reddy’s Laboratories Ltd. will be allowed to sell a generic of Helsinn Healthcare SA’s anti-nausea drug Aloxi starting in 2018, according to a settlement announced Tuesday ending more than four years of patent litigation. Correction: An earlier version of this story referred to the wrong patent suit involving Helsinn, Dr. Reddy’s and Aloxi.
-
July 08, 2014
Roche, Helsinn Sue Dr. Reddy's Over Generic Aloxi
Roche Palo Alto LLC and Helsinn Healthcare SA hit Dr. Reddy's Laboratories Ltd. with a complaint in New Jersey federal court on Monday, alleging that the generic-drug maker's proposed version of the anti-nausea drug Aloxi would infringe one of their patents.